Cargando…
Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts
Monocyte chemoattractant protein‐induced protein 1 (MCPIP1, alias Regnase 1) is a negative regulator of inflammation, acting through cleavage of transcripts coding for proinflammatory cytokines and by inhibition of NFκB activity. Moreover, it was demonstrated that MCPIP1 regulates lipid metabolism b...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988450/ https://www.ncbi.nlm.nih.gov/pubmed/34058074 http://dx.doi.org/10.1111/febs.16040 |
_version_ | 1784682963035750400 |
---|---|
author | Pydyn, Natalia Żurawek, Dariusz Kozieł, Joanna Kus, Edyta Wojnar‐Lason, Kamila Jasztal, Agnieszka Fu, Mingui Jura, Jolanta Kotlinowski, Jerzy |
author_facet | Pydyn, Natalia Żurawek, Dariusz Kozieł, Joanna Kus, Edyta Wojnar‐Lason, Kamila Jasztal, Agnieszka Fu, Mingui Jura, Jolanta Kotlinowski, Jerzy |
author_sort | Pydyn, Natalia |
collection | PubMed |
description | Monocyte chemoattractant protein‐induced protein 1 (MCPIP1, alias Regnase 1) is a negative regulator of inflammation, acting through cleavage of transcripts coding for proinflammatory cytokines and by inhibition of NFκB activity. Moreover, it was demonstrated that MCPIP1 regulates lipid metabolism both in adipose tissue and in hepatocytes. In this study, we investigated the effects of tissue‐specific Mcpip1 deletion on the regulation of hepatic metabolism and development of nonalcoholic fatty liver disease (NAFLD). We used control Mcpip1(fl/fl) mice and animals with deletion of Mcpip1 in myeloid leukocytes (Mcpip1(fl/fl)LysM(Cre)) and in hepatocytes (Mcpip1(fl/fl)Alb(Cre)), which were fed chow or a high‐fat diet (HFD) for 12 weeks. Mcpip1(fl/fl)LysM(Cre) mice fed a chow diet were characterized by a significantly reduced hepatic expression of genes regulating lipid and glucose metabolism, which subsequently resulted in low plasma glucose level and dyslipidemia. These animals also displayed systemic inflammation, demonstrated by increased concentrations of cytokines in the plasma and high Tnfa, Il6, IL1b mRNA levels in the liver and brown adipose tissue (BAT). Proinflammatory leukocyte infiltration into BAT, together with low expression of Ucp1 and Ppargc1a, resulted in hypothermia of 22‐week‐old Mcpip1(fl/fl)LysM(Cre) mice. On the other hand, there were no significant changes in phenotype in Mcpip1(fl/fl)Alb(Cre) mice. Although we detected a reduced hepatic expression of genes regulating glucose metabolism and β‐oxidation in these mice, they remained asymptomatic. Upon feeding with a HFD, Mcpip1(fl/fl)LysM(Cre) mice did not develop obesity, glucose intolerance, nor hepatic steatosis, but were characterized by low plasma glucose level and dyslipidemia, along with proinflammatory phenotype. Mcpip1(fl/fl)Alb(Cre) animals, following a HFD, became hypercholesterolemic, but accumulated lipids in the liver at the same level as Mcpip1(fl/fl) mice, and no changes in the level of soluble factors tested in the plasma were detected. We have demonstrated that Mcpip1 protein plays an important role in the liver homeostasis. Depletion of Mcpip1 in myeloid leukocytes, followed by systemic inflammation, has a more pronounced effect on controlling liver metabolism and homeostasis than the depletion of Mcpip1 in hepatocytes. |
format | Online Article Text |
id | pubmed-8988450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89884502022-10-14 Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts Pydyn, Natalia Żurawek, Dariusz Kozieł, Joanna Kus, Edyta Wojnar‐Lason, Kamila Jasztal, Agnieszka Fu, Mingui Jura, Jolanta Kotlinowski, Jerzy FEBS J Original Articles Monocyte chemoattractant protein‐induced protein 1 (MCPIP1, alias Regnase 1) is a negative regulator of inflammation, acting through cleavage of transcripts coding for proinflammatory cytokines and by inhibition of NFκB activity. Moreover, it was demonstrated that MCPIP1 regulates lipid metabolism both in adipose tissue and in hepatocytes. In this study, we investigated the effects of tissue‐specific Mcpip1 deletion on the regulation of hepatic metabolism and development of nonalcoholic fatty liver disease (NAFLD). We used control Mcpip1(fl/fl) mice and animals with deletion of Mcpip1 in myeloid leukocytes (Mcpip1(fl/fl)LysM(Cre)) and in hepatocytes (Mcpip1(fl/fl)Alb(Cre)), which were fed chow or a high‐fat diet (HFD) for 12 weeks. Mcpip1(fl/fl)LysM(Cre) mice fed a chow diet were characterized by a significantly reduced hepatic expression of genes regulating lipid and glucose metabolism, which subsequently resulted in low plasma glucose level and dyslipidemia. These animals also displayed systemic inflammation, demonstrated by increased concentrations of cytokines in the plasma and high Tnfa, Il6, IL1b mRNA levels in the liver and brown adipose tissue (BAT). Proinflammatory leukocyte infiltration into BAT, together with low expression of Ucp1 and Ppargc1a, resulted in hypothermia of 22‐week‐old Mcpip1(fl/fl)LysM(Cre) mice. On the other hand, there were no significant changes in phenotype in Mcpip1(fl/fl)Alb(Cre) mice. Although we detected a reduced hepatic expression of genes regulating glucose metabolism and β‐oxidation in these mice, they remained asymptomatic. Upon feeding with a HFD, Mcpip1(fl/fl)LysM(Cre) mice did not develop obesity, glucose intolerance, nor hepatic steatosis, but were characterized by low plasma glucose level and dyslipidemia, along with proinflammatory phenotype. Mcpip1(fl/fl)Alb(Cre) animals, following a HFD, became hypercholesterolemic, but accumulated lipids in the liver at the same level as Mcpip1(fl/fl) mice, and no changes in the level of soluble factors tested in the plasma were detected. We have demonstrated that Mcpip1 protein plays an important role in the liver homeostasis. Depletion of Mcpip1 in myeloid leukocytes, followed by systemic inflammation, has a more pronounced effect on controlling liver metabolism and homeostasis than the depletion of Mcpip1 in hepatocytes. John Wiley and Sons Inc. 2021-06-21 2021-11 /pmc/articles/PMC8988450/ /pubmed/34058074 http://dx.doi.org/10.1111/febs.16040 Text en © 2021 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Pydyn, Natalia Żurawek, Dariusz Kozieł, Joanna Kus, Edyta Wojnar‐Lason, Kamila Jasztal, Agnieszka Fu, Mingui Jura, Jolanta Kotlinowski, Jerzy Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts |
title | Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts |
title_full | Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts |
title_fullStr | Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts |
title_full_unstemmed | Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts |
title_short | Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts |
title_sort | role of mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockouts |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988450/ https://www.ncbi.nlm.nih.gov/pubmed/34058074 http://dx.doi.org/10.1111/febs.16040 |
work_keys_str_mv | AT pydynnatalia roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts AT zurawekdariusz roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts AT koziełjoanna roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts AT kusedyta roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts AT wojnarlasonkamila roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts AT jasztalagnieszka roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts AT fumingui roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts AT jurajolanta roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts AT kotlinowskijerzy roleofmcpip1inobesityinducedhepaticsteatosisasdeterminedbymyeloidandliverspecificconditionalknockouts |